ID
30522
Beschrijving
https://clinicaltrials.gov/ct2/show/NCT00344006 Study ID : CDA 714703/005 Clinical Study ID :714703/005 Study Title :A multi-centre, randomised, double-blind, double dummy study comparing the efficacy and safety of chlorproguanil-dapsone-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in children and adolescents in Africa. Patient Level Data : Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier : NCT00344006 Sponsor : GlaxoSmithKline Collaborators : N/A Phase phase :3 Study Recruitment Status : Completed Generic Name : artesunate/chlorproguanil/dapsone Trade Name : LAPDAP + ARTESUNATE Study Indication : Malaria, Falciparum
Link
https://clinicaltrials.gov/ct2/show/NCT00344006
Trefwoorden
Versies (1)
- 11-06-18 11-06-18 - Halim Ugurlu
Houder van rechten
GlaxoSmithKline (GSK)
Geüploaded op
11 juni 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
NCT00344006-Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
Case Report From, Module Number 1.6 (Visits included in this module: Day 4-5-6)
Beschrijving
Home Visit
Alias
- UMLS CUI-1
- C0020043
Beschrijving
Home Visit
Datatype
boolean
Alias
- UMLS CUI [1]
- C0020043
Beschrijving
If No to Home Visit
Datatype
text
Alias
- UMLS CUI [1,1]
- C0020043
- UMLS CUI [1,2]
- C1298908
Beschrijving
remain at home
Datatype
boolean
Alias
- UMLS CUI [1]
- C0946419
Beschrijving
reason for visit
Datatype
text
Alias
- UMLS CUI [1,1]
- C0008952
- UMLS CUI [1,2]
- C0392360
Similar models
Case Report From, Module Number 1.6 (Visits included in this module: Day 4-5-6)
C1298908 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])